Serum cav-1 is disclosed as a biomarker for prostate cancer that has the power to differentiate between prostate cancer and BPH patients.

 
Web www.patentalert.com

< Repellant/deterrence system for animals and method of use

> Compositions and methods for polynucleotide delivery
~ 00482